Aster Capital Management’s Electra Therapeutics, Inc. Common stock ETRA Stock Holding History

Aster Capital Management’s Portfolio ETRA Stock Details ETRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$86K	Buy	+7,643	New	+$94.1K	0.03%	486

Other funds holding ETRA

EQT Fund Management Luxembourg $947M AUM 19.95% 1-Year Est. Return

Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Aster Capital Management's ETRA Position: Q3 2026 in Review

Aster Capital Management opened a new position in Electra Therapeutics, Inc. Common stock (ETRA) in Q3 2026: 7,643 shares worth $86K. The stake represents 0.03% of the portfolio and ranks #486 among its holdings.

12 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.

Aster Capital Management held 7,643 shares of Electra Therapeutics, Inc. Common stock worth $86K as of Q3 2026.
Electra Therapeutics, Inc. Common stock was a new Aster Capital Management position in Q3 2026.
Electra Therapeutics, Inc. Common stock made up 0.03% of Aster Capital Management's portfolio in Q3 2026, its #486 holding.
12 funds tracked by Wall St. Rank held Electra Therapeutics, Inc. Common stock as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.